A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression
City of Hope National Medical Center Duarte, California, United States, 91010 Rocky Mountain Cancer Centers Aurora, Colorado, United States, 80012 US Oncology Regulatory Affairs Corporate Office Aurora, Colorado, United States, 80012 US Oncology Research Investigational Products Center Aurora, Colorado, United States, 80012 Henry Ford Hospital Detroit, Michigan, United States, 48202 Texas Oncology – Baylor Dallas, Texas, United States, 75246 Texas Oncology-Tyler Tyler, Texas, United States, 75702 St John of God Murdoch Hospital Murdoch, Western Australia, Australia, 6150 Universitaetsklinikum Salzburg Salzburg, Austria, 5020 Universite Catholique de Louvain Cliniques Universitaires Saint Luc Bruxelles, Belgium, 1200 Grand Hopital de Charleroi Charleroi, Belgium, 6000 Universitair Ziekenhuis Antwerpen Edegem, Belgium, 2650 Universitair Ziekenhuis Gent Gent, Belgium, 9000 Universitair Ziekenhuis Leuven – Campus Gasthuisberg Leuven, Belgium, 3000 European Interbalkan Medical Center Thessaloniki, Greece, 57001 Orszagos Onkologiai Intezet Budapest, Hungary, 1122 Kindai University Hospital Osakasayama-shi, Osaka, Japan, 589-8511 National Cancer Center Hospital Chuo-ku, Tokyo, Japan, 104-0045 The Cancer Institute Hospital of Japanese Foundation for Cancer Research Koto-ku, Tokyo, Japan, 135-8550 Seoul National University Hospital Seoul, Korea, Republic of, 03080 Severance Hospital Yonsei University Health System Seoul, Korea, Republic of, 03722 Samsung Medical Center Seoul, Korea, Republic of, 135-710 Asan Medical Center Seoul, Korea, Republic of, 138-736 Instytut Centrum Zdrowia Matki Polki Lodz, Poland, 93-338 Centrum Medyczne Pratia Poznan Skorzewo, Poland, 60-185 Hospital Clinico Universitario Virgen de la Victoria Malaga, Andalucía, Spain, 29010 Hospital Clinico Universitario de Santiago Santiago de Compostela, Galicia, Spain, 15706

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 5, 2022Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Comments